PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 78 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,006 | +80.1% | 6,730 | 0.0% | 0.00% | – |
| Q2 2023 | $1,114 | -93.6% | 6,730 | -62.0% | 0.00% | – |
| Q1 2023 | $17,304 | +30.7% | 17,730 | +39.3% | 0.00% | – |
| Q4 2022 | $13,239 | -87.7% | 12,730 | -64.4% | 0.00% | – |
| Q1 2022 | $108,000 | -33.7% | 35,776 | -17.0% | 0.00% | – |
| Q4 2021 | $163,000 | -55.0% | 43,120 | -38.4% | 0.00% | – |
| Q3 2021 | $362,000 | +36100.0% | 70,055 | +23251.7% | 0.00% | – |
| Q1 2021 | $1,000 | – | 300 | +435.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 56 | -91.5% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 656 | +9.3% | 0.00% | – |
| Q4 2019 | $2,000 | -89.5% | 600 | -89.1% | 0.00% | – |
| Q3 2019 | $19,000 | +375.0% | 5,500 | +587.5% | 0.00% | – |
| Q2 2019 | $4,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |